We are redefining the speed and integrity of clinical trial execution.
Because patients can't wait.
Know what’s happening at the point of care, while there is still time to act.
Our mission is to change how clinical trials are executed.
For decades, the industry has invested in tools that make execution problems easier to see, yet protocol deviations per pivotal trial are up 56%, Phase 2 and 3 studies still take an average of 60 days to reach database lock, and a single 90-day delay can add more than $5 million in direct costs.¹
Visibility alone hasn't solved the problem. Execution issues get identified, but rarely become timely, coordinated action — the familiar "everyone's problem and no one's problem" dynamic that lets the same failures repeat.
TruTechnologies is building a different operating model. Instead of waiting weeks for problems to surface in EDC or reconciliation, we guide execution as the work is being done, capturing source-level data at the point of care, preventing avoidable deviations before they happen, and routing the risks that matter to the right person while there's still time to protect the study.
Visibility becomes accountability. Detection becomes action. Trials stay on track, and therapies reach patients sooner.
¹ Tufts Center for the Study of Drug Development, Addressing the Execution Translation Gap in Clinical Trials, May 2026.
Mission-driven. Numbers-backed.
Up to 97% reduction in source data errors
Live capture removes the transcription gap where errors are born.
Up to 98% fewer sample-related queries
Protocol-guided workflows catch issues at the point of care.
Up to 85% less sponsor time on sample tracking
Operational fragmentation is replaced with a single live view.
Potential 3-month reduction in time to market
Faster decisions and cleaner data shorten the path to lock.